Infectious Disease Diagnostics Market Size, Trends, Growth Drivers and Future Outlook

Infectious Disease Diagnostics Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Product (Kits & Reagents, Instruments, and Software & Services), Technology  (Biosensor-Based, Immunodiagnostics, Molecular-Based Diagnostic Techniques, Clinical Biology, and Others), Application Type (Laboratory Testing and Point-of-Care Testing), Testing Type (Human Testing and Veterinary Testing), End User (Diagnostic Laboratories, Hospitals & Clinics, Research Institutes, Homecare Settings, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)

Publication Month : Nov 2023

  • Report Code : TIPHE100001430
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 280
Inquire Before Buy

PRICING

$5190

$4152

[Research Report] The infectious disease diagnostics market is expected to grow from US$ 38,366.38 million in 2022 to US$ 59,954.22 million by 2030; it is anticipated to register a CAGR of 5.7% from 2022 to 2030. 

Market Insights and Analyst View:

The infectious disease diagnostics market size is expanding with the rising cases of infectious diseases and increasing product launches and product approvals due to development of technologically advanced products. In May 2022, BD launched its fully automated, high-throughput infectious disease molecular diagnostic platform—BD COR MX instrument—in the US. This instrument automates and integrates the complete molecular laboratory workflow, from the processing of samples to the result of the diagnostic test for large, high-throughput labs. The BD COR System eliminates the task of sorting specimens, aiding the lab tech to have minimal interaction with the specimen, thereby freeing up time for other critical lab processes. In response to the growing cases of infectious diseases and the shortage of laboratory capabilities and molecular testing reagents, some diagnostic testing manufacturers offer rapid and easy-to-use devices to facilitate out-of-laboratory testing.    

Growth Drivers and Challenges:

Veterinary infectious diseases negatively impact the health of domestic animals, livestock, and wildlife. As a result of intensive animal farming, there are conditions for the emergence and amplification of disease epidemics due to the genetic and physical proximity of the billions of animals, often in frail health, that are raised indoors every year. Moreover, animal farming contributes to the spread of infections from wild animals due to deforestation caused by the expansion of agricultural land use.

Diagnostic technologies that can detect emerging infectious animal diseases at an early stage are essential to reduce economic losses associated with outbreaks of such diseases. Polymerase chain reaction (PCR) remains the most widely used molecular assay globally to detect animal pathogens. Diagnostic methods of this type are easy to use, cost-effective, susceptible, and specific, with the ability to detect at a high volume.

Even though conventional virological methods are incredibly reliable, they are time-consuming and labor-intensive procedures. Lateral flow and enzyme-linked immunosorbent assay can be used for rapid detection. Multiplex bead immuno or Luminex assay is a fluorescent beads-based high-throughput quantitative technique used for the detection of multiple antibodies specific for different infectious diseases at the same time in a single reaction, leading to more rapid, economical, and accurate results compared with conventional ELISA. In addition, the protein chip based on surface plasmon resonance (SPR) appears to be a rapid valuable tool in the sero-diagnosis of infection or antibody titration. Recombinant antibodies can also be produced in heterologous systems by using rDNA technology and used for developing diagnostic tests.

Point-of-care diagnostics (POCDs) are simple, rapid, and portable diagnostic devices that can detect the disease status at the field level. In recent years, real-time PCR (qPCR) has been transitioned into a POCD platform. These fully automated platforms combine nucleic acid extraction, thermal cycling, and on-site reporting results. For instance, MiniLab from Enigma Diagnostics is a molecular diagnostic platform of 10–35 kg that is carried at the field level and used for validating African swine fever virus, classical swine fever virus, avian influenza virus, and foot-and-mouth disease virus for research purposes. The genesig detection kits of Primerdesign Ltd, UK supply lyophilized qPCR assay kits for the diagnosis of 62 bovine, 42 equine, 47 porcine, 60 avian, 40 canine, and 26 feline pathogens for research purposes. Similarly, Boster offers Bosterbio qPCR kits to detect up to 48 individual or pooled samples. It is used for gene expression profiling, target DNA quantification, microbial detection, viral or bacterial pathogen load determination, and evaluation of primer pair performance for probe-based qPCR.

Thus, diagnostics methods such as PCR and qPCR to diagnose bacterial, viral, fungal, and parasitic infections in animals is fueling the diagnostics in veterinary diagnosis.

Low reimbursement rates for most diagnostic tests discourage manufacturing companies from developing new tests and conducting research on a large scale to support widespread use. Also, reimbursement remains low if there is data with no expected results to support the cost-effectiveness of the new test or prove the existing test.

Difficulties and concerns about the reimbursement of new or expensive diagnostic tests can impede innovation and pose significant challenges to the widespread deployment of diagnostic technologies. In the US, reimbursement comprises coverage by third-party payers, coding of health services or conditions to determine payment, and determination of payment level.   

For outpatient tests with Current Procedural Terminology (CPT) codes, the Medicare Coverage Advisory Committee promotes the Centers for Medicare & Medicaid Services (CMS) regarding diagnostic test coverage, including the determination of sufficient evidence and health benefits. However, most Medicare reimbursement decisions are made locally and not at the national level. Coverage for diagnostic tests differs as per region. Also, the lack of standards in determining coverage can pose challenges for the development and availability of a new diagnostic product.

In some cases, the reimbursement does not cover test cost, which limits laboratories in offering the test and reduces test availability and use. In other cases, the charge may be high but may leave a considerable cost to the patient, which limits physicians from ordering the test routinely. Compliance and billing remain challenges for clinical laboratories and limit testing availability. Thus, the inadequate reimbursement scenario hinders the growth of the infectious disease diagnostics market.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Infectious Disease Diagnostics Market: Strategic Insights

infectious-disease-diagnostics-market
Market Size Value inUS$ 38,366.38 million in 2022
Market Size Value byUS$ 59,954.22 million by 2030
Growth rateCAGR of 5.7% from 2022 to 2030
Forecast Period2022-2030
Base Year2022
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Report Segmentation and Scope:

The infectious disease diagnostics market, by product, is segmented into kits & reagents, instruments, and software & services. The infectious disease diagnostics market, by technology, is segmented into biosensor-based, immunodiagnostics, molecular-based diagnostic, clinical biology, and others. The market for the immunodiagnostics segment is further segmented into enzyme-linked immunosorbent assay, western blotting analysis, and immunofluorescence assay. The market for the molecular-based diagnostic techniques segment is further segmented into polymerase chain reaction, in situ hybridization, isothermal nucleic acid amplification technology, next generation sequencing, DNA microarrays, and others. The infectious disease diagnostics market, by application type, is bifurcated into point-of-care testing and laboratory testing. The infectious disease diagnostics market, by testing type, is bifurcated into human testing and veterinary testing. The market for the human testing segment is further segmented into HIV, Hepatitis, HAIs, HPV, tuberculosis, influenza, and others. The infectious disease diagnostics market, by end user, is segmented into diagnostic laboratories, hospitals and clinics, research institutes, homecare settings, and others. Based on geography, the infectious disease diagnostics market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Segmental Analysis:

The infectious disease diagnostics market, by product, is segmented into kits & reagents, instruments, and software & services. In 2022, the kits & reagents segment held the largest share of the market. However, the market for the software & services segment is expected to grow at the fastest rate during 2022–2030. The kits and reagents segment is growing due to the presence of a large number of manufacturers such as Abbott; F. Hoffmann-La Roche Ltd; and Bio-Rad Laboratories, Inc. Further, in response to the growing cases of infectious diseases such as HAIs, influenza, and HIV and shortages of laboratory-based molecular testing capacity and reagents, multiple diagnostic test manufacturers have developed and begun selling rapid and easy-to-use devices to facilitate testing outside of laboratory settings. Moreover, kits and reagents are frequently used in various research processes, and there is a constant rise in product launches. For instance, in July 2021, Cepheid announced that it had received CE-IVD clearance for Xpert HIV-1 Viral Load XC and Xpert HIV-1 Qual XC, next-generation extended-coverage (XC) tests for HIV testing. Xpert HIV-1 Viral Load XC provides a second target for HIV-1 detection that provides extended strain coverage to improve performance and reduce the risk of false negative results due to gene mutations or deletions. Hence, owing to the presence of the various market players that are offering multiple reagents & kits and the rise in technological advancements, the segment is expected to grow during the forecast period.

The software and service segment is anticipated to grow in the coming years owing to factors such as rising technological advancement and the adoption of new software to reduce the infectious disease burden. Many companies are launching software to analyze the rising incidence of infectious diseases, predict trends over time and breakout situations, and assess the effectiveness of containment measures. Consequently, several statistical models have been established, primarily based on the susceptible-exposed-infected-recovered or removed (SEIR) model. Additionally, inspired by multidisciplinary and collaborative efforts in the scientific community, the Institute for Disease Modeling has been building modeling tools that result from extensive collaboration among members of research and software teams. These tools provide quantitative and analytical means to represent the transmission of infectious diseases with a model. IDM software tools are freely and openly shared with the scientific community to speed up disease eradication efforts with the help of computational modeling. Thus, such initiatives taken by the key players are also expected to boost the segment growth in the coming years.

Infectious Disease Diagnostics Market, by Product – 2022 and 2030

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Regional Analysis:

Based on geography, the infectious disease diagnostics market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is the largest contributor to the growth of the global infectious disease diagnostics market. Asia Pacific is expected to register the highest CAGR in the infectious disease diagnostics market during 2022–2030. The infectious diseases diagnostics market growth in the US is primarily driven by the increasing prevalence of infectious diseases, rising geriatric population, and growing number of product launches by key players. Aging is a prominent risk factor for infectious diseases, as people above 60 generally have compromised immunity. According to a study published by the Population Reference Bureau in 2020, the population of individuals aged 65 and above was 55 million in the US in 2020, and the number is expected to reach 95 million by 2060. Regulatory agencies in the US are imposing favorable policies for the development of point-of-care (POC) products for the diagnosis and treatment of various indications. In March 2021, the US Food Drug Administration (FDA) authorized Binx Health IO CT/NG Assay for community-based clinics, urgent care settings, and outpatient healthcare facilities; it is the first POC testing product for diagnosing chlamydial and gonorrheal infections. In May 2022, Becton Dickinson and Company (BD), one of the leading global medical technology companies, announced the launch of its new, fully automated, high-throughput molecular diagnostics platform for infectious diseases for the market in the US. The new BD COR MX instrument was launched as an analytical instrument option for the BD COR platform, with 510(k) clearance from the FDA. The BD CTGCTV2 molecular assay, the first test available on the new system, is a single test that detects the three most prevalent non-viral sexually transmitted infections (STIs)—Neisseria gonorrhoeae (GC), Chlamydia trachomatis (CT), and Trichomonas vaginalis (TV). 

Industry Developments and Future Opportunities:

Various initiatives by key players operating in the Infectious Disease Diagnostics Market are listed below:

  1. In January 2023, Trinity Biotech announced a strategic partnership with imaware Inc that combined their built-to-partner digital health platform with Trinity Biotech’s advanced reference laboratory facilities to power the Digital Health Industry with at-home and remote testing programs.
  2. In November 2022, Bio-Rad Laboratories Inc expanded its product portfolio of independent quality controls, including InteliQ and Liquichek compact vials. The products will be used for Abbott's Alinity CI-Series, which is integrated with clinical chemistry and immunoassay testing instruments.
  3. In December 2021, F. Hoffmann-La Roche Ltd launched the first infectious disease tests on the cobas 5800 System, a new molecular laboratory instrument, in countries accepting the CE mark. These include cobas HIV-1, cobas HBV, cobas HCV, cobas HIV-1/HIV-2 Qualitative, and the cobas omni Utility Channel kit. These launches expand the Roche Molecular portfolio offering by providing standardized performance and efficiencies across low, medium, and high-volume molecular laboratory testing needs.

Competitive Landscape and Key Companies:

Abbott Laboratories, Bruker Corp, Cardinal Health, F. Hoffmann-La Roche Ltd, Trinity Biotech Plc, Danaher Corp, Bio-Rad Laboratories Inc, AccuBioTech Co Ltd, ACON Laboratories, and DiaSorin SpA are among the prominent players operating in the infectious disease diagnostics market. These companies focus on new product launches and geographic expansions to meet the growing consumer demand across the world and increase their product range in specialty portfolios. Their global presence allows them to serve a large base of customers, subsequently facilitating market expansion.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product, Technology, Application Type, Testing Type, End User, and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving factors for the infectious disease diagnostics market across the country?

The factors that are driving and restraining factors that will affect the infectious disease diagnostics market in the coming years Growth of the global infectious disease diagnostic market is majorly driven by increase in prevalence of infectious disease such as hepatitis, influenza, COVID-19, & human immuno deficiency virus (HIV); rise in demand for point-of-care diagnostic test; increase in funding from private & government organizations for diagnostic service centers; and advancements in technologies in the field of infectious disease diagnostics. However, lack of reimbursement policy is likely to hinder the market growth.

Which segment is dominating the infectious disease diagnostics market?

The infectious disease diagnostics market, by disease indication, is bifurcated into human testing and veterinary testing. In 2022, the human segment held a larger share of the market, by testing type. However, the veterinary segment is expected to witness a higher growth during the forecast period.

Who are the major players in market the infectious disease diagnostics market?

The infectious disease diagnostics market majorly consists of the players such as F.Hoffmann-La Roche, Ltd.; Danaher Corporation; BD; bioMérieux SA; AccuBioTech Co., Ltd.; Bio-Rad Laboratories, Inc.; ACON Laboratories, Inc.; Abbott; Trinity Biotech; and Cardinal Health, Inc. amongst others.

What is the infectious disease diagnostics market?

Infectious diseases are generated by microorganisms such as fungi, viruses, bacteria, and other organism species. Infectious disease diagnostics are the methods utilized by hospitals, clinical laboratories, and others to detect or identify foreign antigens/organisms by using several diagnostic tests. These tests assist in the identification of the kind of pathogen. Also, the level of the degree to which the disease is spread in the body. The diagnostic procedure may be sent with the aid of conventional diagnostic tests or point-of-care testing tools.

1. Introduction 39

1.1 The Insight Partners Research Report Guidance. 39

1.2 Market Segmentation. 40

2. Executive Summary 42

2.1 Key Insights. 42

2.2 Infectious Disease Diagnostics Market, by Geography (US$ Million) 43

3. Research Methodology 44

3.1 Coverage. 45

3.2 Secondary Research. 45

3.3 Primary Research. 45

4. Infectious Disease Diagnostics Market Landscape 47

4.1 Overview. 47

4.2 PEST Analysis. 47

4.2.1 Global PEST Analysis. 47

5. Infectious Disease Diagnostics Market - Key Industry Dynamics 48

5.1 Market Drivers: 48

5.1.1 Rising Incidence of Infectious Diseases. 48

5.1.2 Rising Application of Diagnostics in Veterinary Infectious Disease. 50

5.2 Market Restraints. 50

5.2.1 Inadequate Reimbursement Scenario. 50

5.3 Market Opportunities. 51

5.3.1 Increasing Focus on R&D and Funding in Infectious Disease Diagnostics. 51

5.4 Future Trends. 52

5.4.1 Rising Number of Product Approvals and Launches. 52

5.5 Impact Analysis: 52

6. Infectious Disease Diagnostics Market - Global Market Analysis 54

6.1 Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 – 2030. 54

7. Global Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 – by Product 56

7.1 Overview. 56

7.2 Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%) 56

7.3 Kits & Reagents. 57

7.3.1 Overview. 57

7.3.2 Kits & Reagents: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 57

7.4 Instruments. 58

7.4.1 Overview. 58

7.4.2 Instruments: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 58

7.5 Software & Services. 59

7.5.1 Overview. 59

7.5.2 Software & Services: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 59

8. Global Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 – by Technology 60

8.1 Overview. 60

8.2 Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%) 60

8.3 Biosensor-based. 61

8.3.1 Overview. 61

8.3.2 Biosensor-based: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 61

8.4 Immunodiagnostics. 62

8.4.1 Overview. 62

8.4.2 Immunodiagnostics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 62

8.4.2.1 Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 63

8.5 Molecular-Based Diagnostic Techniques. 64

8.5.1 Overview. 64

8.5.2 Molecular-Based Diagnostic Techniques: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 64

8.5.2.1 Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 64

8.6 Clinical Biology. 66

8.6.1 Overview. 66

8.6.2 Clinical Biology: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 66

8.7 Others. 67

8.7.1 Overview. 67

8.7.2 Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 67

9. Global Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 – by Application Type 68

9.1 Overview. 68

9.2 Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%) 68

9.3 Point-of-Care Testing. 69

9.3.1 Overview. 69

9.3.2 Point-of-Care Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 69

9.4 Laboratory Testing. 70

9.4.1 Overview. 70

9.4.2 Laboratory Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 70

10. Global Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 – by Testing Type 71

10.1 Overview. 71

10.2 Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%) 71

10.3 Human Testing. 72

10.3.1 Overview. 72

10.3.2 Human Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 72

10.3.2.1 Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 73

10.4 Veterinary Testing. 74

10.4.1 Overview. 74

10.4.2 Veterinary Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 74

11. Global Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 – by End User 75

11.1 Overview. 75

11.2 Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%) 75

11.3 Diagnostic Laboratories. 76

11.3.1 Overview. 76

11.3.2 Diagnostic Laboratories: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 76

11.4 Hospitals and Clinics. 77

11.4.1 Overview. 77

11.4.2 Hospitals and Clinics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 77

11.5 Research Institutes. 78

11.5.1 Overview. 78

11.5.2 Research Institutes: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 78

11.6 Homecare Settings. 80

11.6.1 Overview. 80

11.6.2 Homecare Settings: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 80

11.7 Others. 81

11.7.1 Overview. 81

11.7.2 Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 81

12. Infectious Disease Diagnostics Market - Geographical Analysis 82

12.1 North America Infectious Disease Diagnostics Market, Revenue and Forecast To 2030. 82

12.1.1 Overview. 82

12.1.2 North America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 83

12.1.3 North America: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 83

12.1.4 North America: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 84

12.1.4.1 North America: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 84

12.1.4.2 North America: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 85

12.1.5 North America: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 85

12.1.6 North America: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 86

12.1.6.1 North America: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 86

12.1.7 North America: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 87

12.1.8 North America Infectious Disease Diagnostics Market, by Country. 87

12.1.8.1 US. 88

12.1.8.1.1 Overview.. 88

12.1.8.1.2 US Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 88

12.1.8.1.3 US: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 88

12.1.8.1.4 US: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 90

12.1.8.1.4.1 US: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 90

12.1.8.1.4.2 US: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 91

12.1.8.1.5 US: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 92

12.1.8.1.6 US: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 92

12.1.8.1.6.1 US: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 92

12.1.8.1.7 US: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 93

12.1.8.2 Canada. 94

12.1.8.2.1 Overview.. 94

12.1.8.2.2 Canada Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 94

12.1.8.2.3 Canada: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 95

12.1.8.2.4 Canada: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 96

12.1.8.2.4.1 Canada: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 96

12.1.8.2.4.2 Canada: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 97

12.1.8.2.5 Canada: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 97

12.1.8.2.6 Canada: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 98

12.1.8.2.6.1 Canada: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 98

12.1.8.2.7 Canada: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 99

12.1.8.3 Mexico. 100

12.1.8.3.1 Overview.. 100

12.1.8.3.2 Mexico Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 100

12.1.8.3.3 Mexico: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 101

12.1.8.3.4 Mexico: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 102

12.1.8.3.4.1 Mexico: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 102

12.1.8.3.4.2 Mexico: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 103

12.1.8.3.5 Mexico: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 103

12.1.8.3.6 Mexico: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 103

12.1.8.3.6.1 Mexico: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 104

12.1.8.3.7 Mexico: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 104

12.2 Europe Infectious Disease Diagnostics Market, Revenue and Forecast to 2030. 105

12.2.1 Overview. 105

12.2.2 Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 106

12.2.3 Europe: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 106

12.2.4 Europe: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 107

12.2.4.1 Europe: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 107

12.2.4.2 Europe: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 108

12.2.5 Europe: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 108

12.2.6 Europe: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 109

12.2.6.1 Europe: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 109

12.2.7 Europe: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 110

12.2.8 Europe Infectious Disease Diagnostics Market, by Country. 110

12.2.8.1 UK.. 111

12.2.8.1.1 Overview.. 111

12.2.8.1.2 UK Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 111

12.2.8.1.3 UK: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 111

12.2.8.1.4 UK: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 113

12.2.8.1.4.1 UK: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 113

12.2.8.1.4.2 UK: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 114

12.2.8.1.5 UK: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 114

12.2.8.1.6 UK: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 115

12.2.8.1.6.1 UK: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 115

12.2.8.1.7 UK: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 116

12.2.8.2 Germany. 117

12.2.8.2.1 Overview.. 117

12.2.8.2.2 Germany Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 117

12.2.8.2.3 Germany: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 118

12.2.8.2.4 Germany: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 119

12.2.8.2.4.1 Germany: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 119

12.2.8.2.4.2 Germany: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 120

12.2.8.2.5 Germany: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 120

12.2.8.2.6 Germany: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 121

12.2.8.2.6.1 Germany: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 121

12.2.8.2.7 Germany: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 122

12.2.8.3 France. 123

12.2.8.3.1 Overview.. 123

12.2.8.3.2 France Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 123

12.2.8.3.3 France: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 123

12.2.8.3.4 France: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 125

12.2.8.3.4.1 France: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 125

12.2.8.3.4.2 France: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 126

12.2.8.3.5 France: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 126

12.2.8.3.6 France: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 127

12.2.8.3.6.1 France: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 127

12.2.8.3.7 France: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 128

12.2.8.4 Italy. 129

12.2.8.4.1 Overview.. 129

12.2.8.4.2 Italy Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 129

12.2.8.4.3 Italy: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 129

12.2.8.4.4 Italy: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 131

12.2.8.4.4.1 Italy: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 131

12.2.8.4.4.2 Italy: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 132

12.2.8.4.5 Italy: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 132

12.2.8.4.6 Italy: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 132

12.2.8.4.6.1 Italy: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 133

12.2.8.4.7 Italy: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 133

12.2.8.5 Spain. 134

12.2.8.5.1 Overview.. 134

12.2.8.5.2 Spain Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 134

12.2.8.5.3 Spain: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 134

12.2.8.5.4 Spain: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 136

12.2.8.5.4.1 Spain: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 136

12.2.8.5.4.2 Spain: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 137

12.2.8.5.5 Spain: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 137

12.2.8.5.6 Spain: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 137

12.2.8.5.6.1 Spain: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 138

12.2.8.5.7 Spain: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 138

12.2.8.6 Rest of Europe. 139

12.2.8.6.1 Overview.. 139

12.2.8.6.2 Rest of Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 139

12.2.8.6.3 Rest of Europe: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 139

12.2.8.6.4 Rest of Europe: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 141

12.2.8.6.4.1 Rest of Europe: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 141

12.2.8.6.4.2 Rest of Europe: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 142

12.2.8.6.5 Rest of Europe: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 142

12.2.8.6.6 Rest of Europe: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 143

12.2.8.6.6.1 Rest of Europe: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 143

12.2.8.6.7 Rest of Europe: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 144

12.3 Asia Pacific Infectious Disease Diagnostics Market, Revenue and Forecast to 2030. 145

12.3.1 Overview. 145

12.3.2 Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 146

12.3.3 Asia Pacific: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 146

12.3.4 Asia Pacific: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 147

12.3.4.1 Asia Pacific: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 147

12.3.4.2 Asia Pacific: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 148

12.3.5 Asia Pacific: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 148

12.3.6 Asia Pacific: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 149

12.3.6.1 Asia Pacific: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 149

12.3.7 Asia Pacific: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 150

12.3.8 Asia Pacific Infectious Disease Diagnostics Market, by Country. 151

12.3.8.1 China. 151

12.3.8.1.1 Overview.. 151

12.3.8.1.2 China Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 151

12.3.8.1.3 China: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 153

12.3.8.1.4 China: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 153

12.3.8.1.4.1 China: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 154

12.3.8.1.4.2 China: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 154

12.3.8.1.5 China: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 155

12.3.8.1.6 China: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 155

12.3.8.1.6.1 China: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 156

12.3.8.1.7 China: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 156

12.3.8.2 Japan. 157

12.3.8.2.1 Overview.. 157

12.3.8.2.2 Japan Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 157

12.3.8.2.3 Japan: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 157

12.3.8.2.4 Japan: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 159

12.3.8.2.4.1 Japan: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 159

12.3.8.2.4.2 Japan: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 160

12.3.8.2.5 Japan: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 160

12.3.8.2.6 Japan: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 160

12.3.8.2.6.1 Japan: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 161

12.3.8.2.7 Japan: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 161

12.3.8.3 India. 162

12.3.8.3.1 Overview.. 162

12.3.8.3.2 India Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 162

12.3.8.3.3 India: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 162

12.3.8.3.4 India: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 164

12.3.8.3.4.1 India: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 164

12.3.8.3.4.2 India: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 165

12.3.8.3.5 India: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 165

12.3.8.3.6 India: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 165

12.3.8.3.6.1 India: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 166

12.3.8.3.7 India: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 166

12.3.8.4 South Korea. 167

12.3.8.4.1 Overview.. 167

12.3.8.4.2 South Korea Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 167

12.3.8.4.3 South Korea: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 167

12.3.8.4.4 South Korea: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 169

12.3.8.4.4.1 South Korea: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 169

12.3.8.4.4.2 South Korea: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 170

12.3.8.4.5 South Korea: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 170

12.3.8.4.6 South Korea: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 170

12.3.8.4.6.1 South Korea: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 171

12.3.8.4.7 South Korea: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 171

12.3.8.5 Australia. 172

12.3.8.5.1 Overview.. 172

12.3.8.5.2 Australia Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 172

12.3.8.5.3 Australia: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 172

12.3.8.5.4 Australia: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 174

12.3.8.5.4.1 Australia: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 174

12.3.8.5.4.2 Australia: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 175

12.3.8.5.5 Australia: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 175

12.3.8.5.6 Australia: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 175

12.3.8.5.6.1 Australia: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 176

12.3.8.5.7 Australia: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 176

12.3.8.6 Rest of Asia Pacific. 177

12.3.8.6.1 Overview.. 177

12.3.8.6.2 Rest of Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 177

12.3.8.6.3 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 177

12.3.8.6.4 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 179

12.3.8.6.4.1 Rest of Asia Pacific: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 179

12.3.8.6.4.2 Rest of Asia Pacific: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 180

12.3.8.6.5 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 180

12.3.8.6.6 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 181

12.3.8.6.6.1 Rest of Asia Pacific: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 181

12.3.8.6.7 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 182

12.4 Middle East & Africa Infectious Disease Diagnostics Market, Revenue and Forecast to 2030. 183

12.4.1 Overview. 183

12.4.2 Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 184

12.4.3 Middle East & Africa: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 184

12.4.4 Middle East & Africa: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 185

12.4.4.1 Middle East & Africa: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 185

12.4.4.2 Middle East & Africa: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 186

12.4.5 Middle East & Africa: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 186

12.4.6 Middle East & Africa: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 187

12.4.6.1 Middle East & Africa: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 187

12.4.7 Middle East & Africa: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 188

12.4.7.1 Middle East & Africa Infectious Disease Diagnostics Market, by Country. 188

12.4.7.2 Saudi Arabia. 189

12.4.7.2.1 Overview.. 189

12.4.7.2.2 Saudi Arabia Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 189

12.4.7.2.3 Saudi Arabia: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 189

12.4.7.2.4 Saudi Arabia: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 191

12.4.7.2.4.1 Saudi Arabia: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 191

12.4.7.2.4.2 Saudi Arabia: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 192

12.4.7.2.5 Saudi Arabia: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 192

12.4.7.2.6 Saudi Arabia: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 192

12.4.7.2.6.1 Saudi Arabia: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 193

12.4.7.2.7 Saudi Arabia: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 193

12.4.7.3 South Africa. 194

12.4.7.3.1 Overview.. 194

12.4.7.3.2 South Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 194

12.4.7.3.3 South Africa: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 194

12.4.7.3.4 South Africa: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 196

12.4.7.3.4.1 South Africa: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 196

12.4.7.3.4.2 South Africa: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 197

12.4.7.3.5 South Africa: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 197

12.4.7.3.6 South Africa: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 197

12.4.7.3.6.1 South Africa: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 198

12.4.7.3.7 South Africa: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 198

12.4.7.4 UAE. 199

12.4.7.4.1 Overview.. 199

12.4.7.4.2 UAE Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 199

12.4.7.4.3 UAE: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 199

12.4.7.4.4 UAE: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 201

12.4.7.4.4.1 UAE: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 201

12.4.7.4.4.2 UAE: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 202

12.4.7.4.5 UAE: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 202

12.4.7.4.6 UAE: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 202

12.4.7.4.6.1 UAE: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 203

12.4.7.4.7 UAE: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 203

12.4.7.5 Rest of Middle East & Africa. 204

12.4.7.5.1 Overview.. 204

12.4.7.5.2 Rest of Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 204

12.4.7.5.3 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 204

12.4.7.5.4 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 206

12.4.7.5.4.1 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 206

12.4.7.5.4.2 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 207

12.4.7.5.5 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 207

12.4.7.5.6 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 208

12.4.7.5.6.1 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 208

12.4.7.5.7 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 209

12.5 South & Central America Infectious Disease Diagnostics Market, Revenue and Forecast to 2030. 210

12.5.1 Overview. 210

12.5.2 South & Central America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 211

12.5.3 South & Central America: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 211

12.5.4 South & Central America: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 212

12.5.4.1 South & Central America: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 212

12.5.4.2 South & Central America: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 213

12.5.5 South & Central America: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 213

12.5.6 South & Central America: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 214

12.5.6.1 South & Central America: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 214

12.5.7 South & Central America: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 215

12.5.8 South & Central America Infectious Disease Diagnostics Market, by Country. 215

12.5.8.1 Brazil 216

12.5.8.1.1 Overview.. 216

12.5.8.1.2 Brazil Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 216

12.5.8.1.3 Brazil: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 216

12.5.8.1.4 Brazil: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 218

12.5.8.1.4.1 Brazil: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 218

12.5.8.1.4.2 Brazil: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 219

12.5.8.1.5 Brazil: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 219

12.5.8.1.6 Brazil: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 219

12.5.8.1.6.1 Brazil: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 220

12.5.8.1.7 Brazil: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 220

12.5.8.2 Argentina. 221

12.5.8.2.1 Overview.. 221

12.5.8.2.2 Argentina Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 221

12.5.8.2.3 Argentina: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 221

12.5.8.2.4 Argentina: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 223

12.5.8.2.4.1 Argentina: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 223

12.5.8.2.4.2 Argentina: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 224

12.5.8.2.5 Argentina: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 224

12.5.8.2.6 Argentina: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 224

12.5.8.2.6.1 Argentina: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 225

12.5.8.2.7 Argentina: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 225

12.5.8.3 Rest of South & Central America. 226

12.5.8.3.1 Overview.. 226

12.5.8.3.2 Rest of South & Central America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 226

12.5.8.3.3 Rest of South & Central America: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 226

12.5.8.3.4 Rest of South & Central America: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 227

12.5.8.3.4.1 Rest of South & Central America: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 227

12.5.8.3.4.2 Rest of South & Central America: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 228

12.5.8.3.5 Rest of South & Central America: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 228

12.5.8.3.6 Rest of South & Central America: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 229

12.5.8.3.6.1 Rest of South & Central America: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 229

12.5.8.3.7 Rest of South & Central America: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 230

13. Industry Landscape 231

13.1 Overview. 231

13.2 Growth Strategies Done by the Companies in the Market, (%) 231

13.3 Organic Developments. 232

13.3.1 Overview. 232

13.4 Inorganic Developments. 234

13.4.1 Overview. 234

14. Company Profiles 235

14.1 Abbott Laboratories. 235

14.1.1 Key Facts. 235

14.1.2 Business Description. 235

14.1.3 Products and Services. 236

14.1.4 Financial Overview. 237

14.1.5 SWOT Analysis. 238

14.1.6 Key Developments. 239

14.2 Bruker Corp. 240

14.2.1 Key Facts. 240

14.2.2 Business Description. 240

14.2.3 Products and Services. 241

14.2.4 Financial Overview. 241

14.2.5 SWOT Analysis. 243

14.2.6 Key Developments. 243

14.3 Cardinal Health Inc. 244

14.3.1 Key Facts. 244

14.3.2 Business Description. 244

14.3.3 Products and Services. 245

14.3.4 Financial Overview. 245

14.3.5 SWOT Analysis. 247

14.3.6 Key Developments. 247

14.4 F. Hoffmann-La Roche Ltd. 248

14.4.1 Key Facts. 248

14.4.2 Business Description. 248

14.4.3 Products and Services. 249

14.4.4 Financial Overview. 250

14.4.5 SWOT Analysis. 251

14.4.6 Key Developments. 252

14.5 Trinity Biotech Plc. 253

14.5.1 Key Facts. 253

14.5.2 Business Description. 253

14.5.3 Products and Services. 254

14.5.4 Financial Overview. 254

14.5.5 SWOT Analysis. 256

14.5.6 Key Developments. 256

14.6 Danaher Corp. 257

14.6.1 Key Facts. 257

14.6.2 Business Description. 257

14.6.3 Products and Services. 258

14.6.4 Financial Overview. 258

14.6.5 SWOT Analysis. 260

14.6.6 Key Developments. 260

14.7 Bio-Rad Laboratories Inc. 261

14.7.1 Key Facts. 261

14.7.2 Business Description. 261

14.7.3 Products and Services. 262

14.7.4 Financial Overview. 262

14.7.5 SWOT Analysis. 264

14.7.6 Key Developments. 264

14.8 AccuBioTech Co Ltd. 266

14.8.1 Key Facts. 266

14.8.2 Business Description. 266

14.8.3 Products and Services. 266

14.8.4 Financial Overview. 267

14.8.5 SWOT Analysis. 267

14.8.6 Key Developments. 268

14.9 ACON Laboratories Inc. 269

14.9.1 Key Facts. 269

14.9.2 Business Description. 269

14.9.3 Products and Services. 269

14.9.4 Financial Overview. 270

14.9.5 SWOT Analysis. 271

14.9.6 Key Developments. 271

14.10 DiaSorin SpA. 272

14.10.1 Key Facts. 272

14.10.2 Business Description. 272

14.10.3 Products and Services. 273

14.10.4 Financial Overview. 274

14.10.5 SWOT Analysis. 275

14.10.6 Key Developments. 275

15. Appendix 276

15.1 About Us. 276

15.2 Glossary of Terms. 278

List of Tables

Table 1. Infectious Disease Diagnostics Market Segmentation. 40

Table 2. Infectious Diseases and Fundings. 51

Table 3. Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 63

Table 4. Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 64

Table 5. Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 73

Table 6. North America Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 83

Table 7. North America Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 84

Table 8. North America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 84

Table 9. North America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 85

Table 10. North America Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 85

Table 11. North America Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 86

Table 12. North America Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 86

Table 13. North America Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 87

Table 14. US Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 88

Table 15. US Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 90

Table 16. US Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 90

Table 17. US Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 91

Table 18. US Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 92

Table 19. US Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 92

Table 20. US Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 92

Table 21. US Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 93

Table 22. Canada Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 95

Table 23. Canada Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 96

Table 24. Canada Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 96

Table 25. Canada Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 97

Table 26. Canada Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 97

Table 27. Canada Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 98

Table 28. Canada Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 98

Table 29. Canada Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 99

Table 30. Mexico Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 101

Table 31. Mexico Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 102

Table 32. Mexico Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 102

Table 33. Mexico Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 103

Table 34. Mexico Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 103

Table 35. Mexico Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 103

Table 36. Mexico Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 104

Table 37. Mexico Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 104

Table 38. Europe Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 106

Table 39. Europe Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 107

Table 40. Europe Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 107

Table 41. Europe Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 108

Table 42. Europe Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 108

Table 43. Europe Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 109

Table 44. Europe Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 109

Table 45. Europe Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 110

Table 46. UK Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 111

Table 47. UK Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 113

Table 48. UK Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 113

Table 49. UK Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 114

Table 50. UK Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 114

Table 51. UK Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 115

Table 52. UK Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 115

Table 53. UK Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 116

Table 54. Germany Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 118

Table 55. Germany Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 119

Table 56. Germany Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 119

Table 57. Germany Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 120

Table 58. Germany Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 120

Table 59. Germany Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 121

Table 60. Germany Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 121

Table 61. Germany Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 122

Table 62. France Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 123

Table 63. France Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 125

Table 64. France Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 125

Table 65. France Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 126

Table 66. France Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 126

Table 67. France Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 127

Table 68. France Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 127

Table 69. France Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 128

Table 70. Italy Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 129

Table 71. Italy Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 131

Table 72. Italy Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 131

Table 73. Italy Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 132

Table 74. Italy Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 132

Table 75. Italy Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 132

Table 76. Italy Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 133

Table 77. Italy Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 133

Table 78. Spain Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 134

Table 79. Spain Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 136

Table 80. Spain Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 136

Table 81. Spain Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 137

Table 82. Spain Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 137

Table 83. Spain Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 137

Table 84. Spain Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 138

Table 85. Spain Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 138

Table 86. Rest of Europe Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 140

Table 87. Rest of Europe Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 141

Table 88. Rest of Europe Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 141

Table 89. Rest of Europe Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 142

Table 90. Rest of Europe Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 142

Table 91. Rest of Europe Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 143

Table 92. Rest of Europe Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 143

Table 93. Rest of Europe Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 144

Table 94. Asia Pacific Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 146

Table 95. Asia Pacific Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 147

Table 96. Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 147

Table 97. Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 148

Table 98. Asia Pacific Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 148

Table 99. Asia Pacific Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 149

Table 100. Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 149

Table 101. Asia Pacific Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 150

Table 102. China Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 153

Table 103. China Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 153

Table 104. China Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 154

Table 105. China Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 154

Table 106. China Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 155

Table 107. China Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 155

Table 108. China Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 156

Table 109. China Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 156

Table 110. Japan Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 157

Table 111. Japan Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 159

Table 112. Japan Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 159

Table 113. Japan Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 160

Table 114. Japan Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 160

Table 115. Japan Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 160

Table 116. Japan Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 161

Table 117. Japan Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 161

Table 118. India Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 162

Table 119. India Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 164

Table 120. India Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 164

Table 121. India Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 165

Table 122. India Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 165

Table 123. India Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 165

Table 124. India Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 166

Table 125. India Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 166

Table 126. South Korea Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 167

Table 127. South Korea Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 169

Table 128. South Korea Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 169

Table 129. South Korea Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 170

Table 130. South Korea Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 170

Table 131. South Korea Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 170

Table 132. South Korea Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 171

Table 133. South Korea Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 171

Table 134. Australia Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 172

Table 135. Australia Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 174

Table 136. Australia Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 174

Table 137. Australia Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 175

Table 138. Australia Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 175

Table 139. Australia Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 175

Table 140. Australia Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 176

Table 141. Australia Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 176

Table 142. Rest of Asia Pacific Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 177

Table 143. Rest of Asia Pacific Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 179

Table 144. Rest of Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 179

Table 145. Rest of Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 180

Table 146. Rest of Asia Pacific Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 180

Table 147. Rest of Asia Pacific Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 181

Table 148. Rest of Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 181

Table 149. Rest of Asia Pacific Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 182

Table 150. Middle East & Africa Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 184

Table 151. Middle East & Africa Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 185

Table 152. Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 185

Table 153. Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 186

Table 154. Middle East & Africa Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 186

Table 155. Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 187

Table 156. Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 187

Table 157. Middle East & Africa Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 188

Table 158. Saudi Arabia Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 189

Table 159. Saudi Arabia Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 191

Table 160. Saudi Arabia Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 191

Table 161. Saudi Arabia Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 192

Table 162. Saudi Arabia Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 192

Table 163. Saudi Arabia Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 192

Table 164. Saudi Arabia Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 193

Table 165. Saudi Arabia Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 193

Table 166. Saudi Arabia Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 194

Table 167. South Africa Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 196

Table 168. South Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 196

Table 169. South Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 197

Table 170. South Africa Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 197

Table 171. South Africa Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 197

Table 172. South Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 198

Table 173. South Africa Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 198

Table 174. UAE Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 199

Table 175. UAE Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 201

Table 176. UAE Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 201

Table 177. UAE Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 202

Table 178. UAE Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 202

Table 179. UAE Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 202

Table 180. UAE Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 203

Table 181. UAE Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 203

Table 182. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 204

Table 183. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 206

Table 184. Rest of Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 206

Table 185. Rest of Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 207

Table 186. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 207

Table 187. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 208

Table 188. Rest of Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 208

Table 189. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 209

Table 190. South & Central America Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 211

Table 191. South & Central America Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 212

Table 192. South & Central America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 212

Table 193. South & Central America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 213

Table 194. South & Central America Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 213

Table 195. South & Central America Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 214

Table 196. South & Central America Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 214

Table 197. South & Central America Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 215

Table 198. Brazil Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 216

Table 199. Brazil Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 218

Table 200. Brazil Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 218

Table 201. Brazil Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 219

Table 202. Brazil Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 219

Table 203. Brazil Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 219

Table 204. Brazil Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 220

Table 205. Brazil Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 220

Table 206. Argentina Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 221

Table 207. Argentina Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 223

Table 208. Argentina Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 223

Table 209. Argentina Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 224

Table 210. Argentina Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 224

Table 211. Argentina Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 224

Table 212. Argentina Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 225

Table 213. Argentina Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 225

Table 214. Rest of South & Central America Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 226

Table 215. Rest of South & Central America Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 227

Table 216. Rest of South & Central America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 227

Table 217. Rest of South & Central America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 228

Table 218. Rest of South & Central America Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 228

Table 219. Rest of South & Central America Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 229

Table 220. Rest of South & Central America Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 229

Table 221. Rest of South & Central America Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 230

Table 222. Organic Developments Done By Companies. 232

Table 223. Inorganic Developments Done By Companies. 234

Table 224. Glossary of Terms, Infectious Disease Diagnostics Market 278

List of Figures

Figure 1. Infectious Disease Diagnostics Market Segmentation, By Geography. 41

Figure 2. Global - PEST Analysis. 47

Figure 3. Infectious Disease Diagnostics Market - Key Industry Dynamics. 48

Figure 4. Impact Analysis of Drivers and Restraints. 53

Figure 5. Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 – 2030. 54

Figure 6. Infectious Disease Diagnostics Market Revenue, Geography (US$ Mn), 2022 – 2030. 55

Figure 7. Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%) 56

Figure 8. Kits & Reagents: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 57

Figure 9. Instruments: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 58

Figure 10. Software & Services: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 59

Figure 11. Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%) 60

Figure 12. Biosensor-based: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 61

Figure 13. Immunodiagnostics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 62

Figure 14. Molecular-Based Diagnostic Techniques: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 64

Figure 15. Clinical Biology: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 66

Figure 16. Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 67

Figure 17. Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%) 68

Figure 18. Point-of-Care Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 69

Figure 19. Laboratory Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 70

Figure 20. Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%) 71

Figure 21. Human Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 72

Figure 22. Veterinary Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 74

Figure 23. Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%) 75

Figure 24. Diagnostic Laboratories: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 76

Figure 25. Hospitals and Clinics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 77

Figure 26. Research Institutes: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 78

Figure 27. Homecare Settings: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 80

Figure 28. Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 81

Figure 29. North America: Infectious Disease Diagnostics Market, by Key Country – Revenue (2022) (US$ Million) 82

Figure 30. North America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 83

Figure 31. North America Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%) 87

Figure 32. US Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 88

Figure 33. Canada Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 94

Figure 34. Mexico Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 100

Figure 35. Europe Infectious Disease Diagnostics Market, by Key Country – Revenue, 2022 (US$ Million) 105

Figure 36. Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 106

Figure 37. Europe Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%) 110

Figure 38. UK Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 111

Figure 39. Germany Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 117

Figure 40. France Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 123

Figure 41. Italy Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 129

Figure 42. Spain Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 134

Figure 43. Rest of Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 139

Figure 44. Asia Pacific Infectious Disease Diagnostics Market, by Key Country – Revenue, 2022 (US$ Million) 145

Figure 45. Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 146

Figure 46. Asia Pacific Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%) 151

Figure 47. China Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 151

Figure 48. Japan Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 157

Figure 49. India Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 162

Figure 50. South Korea Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 167

Figure 51. Australia Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 172

Figure 52. Rest of Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 177

Figure 53. Middle East & Africa Infectious Disease Diagnostics Market, by Key Country – Revenue, 2022 (US$ Million) 183

Figure 54. Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 184

Figure 55. Middle East & Africa Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%) 188

Figure 56. Saudi Arabia Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 189

Figure 57. South Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 194

Figure 58. UAE Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 199

Figure 59. Rest of Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 204

Figure 60. South & Central America Infectious Disease Diagnostics Market, by Key Country – Revenue, 2022 (US$ Million) 210

Figure 61. South & Central America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 211

Figure 62. South & Central America Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%) 215

Figure 63. Brazil Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 216

Figure 64. Argentina Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 221

Figure 65. Rest of South & Central America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 226

Figure 66. Growth Strategies Done by the Companies in the Market, (%) 231

The List of Companies - Infectious Disease Diagnostics Market 

  1. Abbott Laboratories
  2. Bruker Corp
  3. Cardinal Health
  4. F. Hoffmann-La Roche Ltd
  5. Trinity Biotech Plc
  6. Danaher Corp
  7. Bio-Rad Laboratories Inc
  8. AccuBioTech Co Ltd
  9. ACON Laboratories
  10. DiaSorin SpA

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Infectious Disease Diagnostics Market